School of Medicine, Nankai University, Tianjin, China.
Department of Ultrasound, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Front Endocrinol (Lausanne). 2020 May 15;11:249. doi: 10.3389/fendo.2020.00249. eCollection 2020.
Papillary thyroid microcarcinoma (PTMC) has a good prognosis and a long survival time. Health-related quality of life (HRQoL) is vital for PTMC patients during their survivorship. Ultrasound (US)-guided radiofrequency ablation (RFA), which has high efficacy and safety, is recommended as an alternative treatment to surgery for the patients with low-risk PTMC. However, the assessment of QoL of patients with PTMC has not been specially reported. The purpose of our study was to compare the HRQoL of patients with PTMC who underwent RFA and those who underwent surgery. From October 2019 to December 2019, 88 PTMC patients were enrolled in our study, including 54 in RFA group and 34 in surgery group. We used three questionnaires which included the 36-item short form health survey (SF-36), thyroid cancer-specific quality of life (THYCA-QOL), and Fear of Progression Questionnaire-Short Form (FoP-Q-SF) for each patient to evaluate their scores of HRQoL. The scores were compared after adjusting for age, sex, medical expense, and follow-up time. According to the SF-36, the scores of the domain for the role limitation due to physical problems and emotional problems (RP, RE) as well as Physical Component Summary (PCS) showed a significant negative linear association between the RFA group and surgery group: RP coefficient [coef]-22.613 [confidence interval (CI) -33.504 to -11.723], < 0.001, RE (coef: -21.901 [CI -36.737 to -7.064], = 0.004), and PCS (coef: -8.312 [CI -13.694 to -2.930], = 0.003). The THYCA-QOL showed that the scores of the surgery group were higher than that of the RFA group regarding scars (coef: 10.246 [CI 1.330 to 19.162], = 0.025 according to the multivariate analysis), suggesting a higher level of complaint in the surgery group. There was no statistically significant difference in the scores of FoP-Q-SF between the two groups. In patients with PTMC, US-guided RFA offers advantage over surgery in terms of HRQoL, which supports the role of RFA as an alternative strategy to surgery.
甲状腺微小乳头状癌(PTMC)预后良好,生存时间长。健康相关生活质量(HRQoL)对于 PTMC 患者的生存至关重要。超声引导下射频消融(RFA)具有高效和安全的特点,被推荐作为低危 PTMC 患者的替代治疗方法。然而,PTMC 患者的 QoL 评估尚未专门报道。我们的研究目的是比较接受 RFA 和手术治疗的 PTMC 患者的 HRQoL。
2019 年 10 月至 12 月,我们纳入了 88 例 PTMC 患者,其中 RFA 组 54 例,手术组 34 例。我们使用了三个问卷,包括 36 项简明健康调查问卷(SF-36)、甲状腺癌特异性生活质量问卷(THYCA-QOL)和进展恐惧问卷短表(FoP-Q-SF),对每位患者的 HRQoL 评分进行评估。调整年龄、性别、医疗费用和随访时间后,比较了评分。
根据 SF-36,RFA 组和手术组的身体问题和情绪问题(RP、RE)以及生理成分综合评分(PCS)的领域评分呈显著负线性相关:RP 系数[系数]-22.613[置信区间(CI)-33.504 至-11.723], <0.001,RE(系数:-21.901[CI-36.737 至-7.064], = 0.004)和 PCS(系数:-8.312[CI-13.694 至-2.930], = 0.003)。THYCA-QOL 显示,手术组在疤痕方面的评分高于 RFA 组(系数:10.246[CI 1.330 至 19.162],根据多变量分析, = 0.025),提示手术组的抱怨程度更高。两组之间 FoP-Q-SF 的评分无统计学差异。
在 PTMC 患者中,超声引导下 RFA 在 HRQoL 方面优于手术,支持 RFA 作为手术替代策略的作用。